| Filed On | Filing |
|---|---|
| 16 Oct 2026 |
8-K: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
On October 15, 2026, Erasca, Inc. (the Company) decided to realign its leadership responsibilities to support the development and potential commercialization of its RAS-targeting programs. Responsibilities currently overseen by the Chief... |
| 15 Oct 2026 | 144 |
| 15 Sep 2026 | 144 |
| 24 Aug 2026 | 8-K: Other Events |
| 17 Aug 2026 | 144 |
| 14 Aug 2026 | SCHEDULE 13G/A |
| 12 Aug 2026 |
Form 4: Fuchs Charles S., President, R&D
Granted 1,300,000 Stock option (right to buy) |
| 12 Aug 2026 |
Form 3: Fuchs Charles S., President, R&D
No securities owned |
| 11 Aug 2026 | S-8 |
| 11 Aug 2026 | 10-Q |
| 11 Aug 2026 | 8-K: Results of Operations and Financial Condition |
| 10 Aug 2026 | 8-K: Departure/Election of Directors or Officers; Compensation |
| 21 Jul 2026 | 144 |
| 14 Jul 2026 | 424B5 |
| 14 Jul 2026 | 8-K: Other Events |
| 13 Jul 2026 | 424B5 |
| 13 Jul 2026 | S-3ASR |
| 13 Jul 2026 | 8-K: Other Events |
| 01 Jul 2026 | 8-K: Submission of Matters to a Vote of Security Holders |
| 29 Jun 2026 |
Form 4: Start Valerie Denise Harding, Director
Granted 29,888 Stock option (right to buy) |
Loading...
